News | August 05, 2011

Gold Nanoparticles Could Help Deliver One-Two Punch To Cancer, Suggests Early Research

August 5, 2011 – Microscopic gold particles could multiply the effectiveness of standard cancer radiation therapy by acting as tiny missiles that destroy blood vessels feeding cancerous tumors. Early research about this method, which could shorten cancer treatment and make it more effective, was presented at the 2011 Joint Meeting of the American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP).

The addition of gold nanoparticles to radiation therapy is a new approach to improving cancer treatments. The study presented focuses on the combination of gold nanoparticles and brachytherapy, a type of radiation treatment in which rice-sized low-energy radiation-emitting seeds are implanted near or within cancerous tumors. Like other forms of radiation therapy, brachytherapy damages the DNA of cancer cells, leading to their death. Supplementing brachytherapy with gold nanoparticles would add a new cancer-killing mechanism that collapses the blood vessels, effectively strangling the tumor, the research suggests.

“The idea is to deliver a one-two punch to the cancer: bombard the tumor with standard radiation therapy while also attacking its blood supply,” said Ross I. Berbeco, Ph.D., lead author of the study and staff physicist at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and assistant professor at Harvard Medical School, Boston. “Although we have also shown that the concept may work for external beam radiation therapy, brachytherapy is particularly attractive for this idea due to the way this low-energy type of radiation interacts with the gold.”

The research suggests that gold nanoparticles may act as a vascular disrupting agent (VDA), cutting off the flow of blood to the tumor by destroying the cells that line tumor-feeding blood vessels. Most VDAs are delivered through chemotherapy, and studies have shown supplementing radiation with VDA chemotherapy may improve cancer treatment. The Brigham and Women’s research suggests that the gold nanoparticles could destroy the blood vessels at the same time radiation therapy is administered.

To test their concept, researchers performed a computer simulation of gold nanoparticles in a tumor blood vessel cell, where brachytherapy seeds had been placed nearby. Results show the gold nanoparticles boost the radiation dose to the blood vessel cells. The researchers next will test the method in live cancer cells.

“We think this is an exciting opportunity for a low-risk, high-reward procedure that could improve cancer care,” said co-author Wilfred F. Ngwa, Ph.D., research fellow at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston.

One million times smaller than the head of a pin, the nanoparticles would be dispersed in a liquid that could be injected into the blood stream. Molecules or proteins attached to the nanoparticles would direct them to target the tumor blood vessel. Gold is an ideal material for this type of therapy because it is relatively non-toxic and its high atomic number boosts the brachytherapy radiation dose.



Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Contrast-Enhanced Ultrasound Safe and Effective Detector of Liver Cancer
News | Ultrasound Imaging | October 19, 2017
Doctors can effectively detect liver cancer with ultrasound and tiny microbubbles, according to a study announced at...
Study Examines Characteristics of Mobile Mammography Patients
News | Mammography | October 18, 2017
Significant differences were found among women receiving mammography at a cancer center versus those visiting a mobile...
Machine Learning Identifies Breast Lesions Likely to Become Cancer
News | Artificial Intelligence | October 18, 2017
A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
Overlay Init